Search Results - O. A. Nagirnyak
- Showing 1 - 5 results of 5
-
1
Main predictors of in-hospital adverse outcomes in non-ST elevation acute coronary syndrome patients with multivessel disease by Yu. N. Neverova, R. S. Tarasov, O. A. Nagirnyak
Published 2018-08-01Aim. To evaluate the range of risk factors associated with adverse cardiovascular events onset in hospital period of follow-up in patients with non-ST elevation acute coronary syndrome (NSTEACS) with multivessel disease (MD).Material and methods. To the study, under the framework of prospective, sin...
Get full text
Article -
2
THE PREVALENCE OF INTACT CORONARY ARTERIES IN RELATION WITH INDICATIONS FOR SCHEDULED CORONARY ARTERIOGRAPHY by E. V. Korok, A. N. Sumin, M. A. Sinkov, O. A. Nagirnyak, T. Yu. Chichkova, L. S. Barbarash
Published 2016-02-01Aim. To evaluate the prevalence and possible reasons for intact coronary arteries (CA) diagnostics in patients with different indications for scheduled coronary arteriography (CAG).Material and methods. The selection studied, consisted of 711 case histories of patients, underwent scheduled CAG at SR...
Get full text
Article -
3
THE RESULTS OF MYOCARDIAL REVASCULARIZATION IN NON-ST-ELEVATION ACUTE CORONARY SYNDROME PATIENTS AND MULTIVESSEL DISEASE by R. S. Tarasov, Yu. N. Neverova, V. I. Ganyukov, S. V. Ivanov, O. A. Nagirnyak, O. L. Barbarash, L. S. Barbarash
Published 2017-04-01Aim. To evaluate in-hospital and long-term outcomes of treatment in non-ST-elevation acute coronary syndrome (NSTEACS) according to the revascularization strategy.Material and methods. In the study under the framework of singlecenter registry, in 2012-2015, 400 patients included, with NSTEACS and mu...
Get full text
Article -
4
TRANSCATHETER AORTIC VALVE IMPLANTATION AND OPEN AORTIC SURGERY: COMPARATIVE ASSESSMENT OF RESULTS by V. I. Ganyukov, R. S. Tarasov, I. E. Vereshchagin, N. A. Kochergin, A. N. Stasev, O. A. Nagirnyak, L. S. Barbarash
Published 2018-12-01Aim. The aim of this study is to compare hospital and long-term outcomes in patients with low surgical risk after aortic stenosis correction in surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI).Materials and methods. Patients with aortic stenosis (AS) were i...
Get full text
Article -
5
ASSOCIATION OF A LYMPHOTOXIN-α VARIABLE SITE rs1041981 WITH DEVELOPMENT OF LONG-TERM UNFAVORABLE OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST-SEGMENT ELEVATION by E. A. Shmidt, S. A. Berns, I. I. Zhidkova, O. A. Makeeva, I. A. Goncharova, O. A. Nagirnyak, A. V. Klimenkova, M. N. Litvinova, O. L. Barbarash
Published 2018-01-01Lymphotoxin-α (LTA) is a major pro-inflammatory cytokine produced at the early stages of vascular inflammation, taking part in the formation of arterial atherosclerosis and development of coronary heart disease. Functional changes in the gene encoding LTA production may influence the development of...
Get full text
Article